A MAJOR SETBACK TO PFIZER (PharmaBiz)
Early this month Pfizer Inc., world's largest pharmaceutical company, came out with a devastating announcement: It is abandoning the clinical development of its highly promising cholesterol drug, torcetrapib.

Data Presented to FDA Panel Show TAXUS(TM) Drug-Eluting Stents as Safe as Bare-Metal Stents and Far (Antara News)
PARIS, Dec. 11 (ANTARA/PRNewswire-AsiaNet) -- Boston Scientific Corporation (NYSE: BSX) yesterday presented data on its long-term randomized clinical trials to a special U.S. Food and Drug Administration (FDA) panel, showing that the TAXUS(TM) paclitaxel-eluting coronary stent is as safe as bare-metal stents (BMS), and far more effective in keeping arteries open and reducing the need for repeat

FDA approves Spectral's rapid West Nile Virus test (CNW Group via Yahoo! Finance)
Spectral Diagnostics Inc. today reports that its West Nile Virus IgM STATus Test has received marketing approval from the U.S. Food and Drug Administration for clinical use in patients with presumptive West Nile Virus infection.